Topic: Ratiopharm GmbH
Generic drugmaker Teva Pharmaceutical ( TEVA) reported second-quarter earnings of $984 million, or $1.10 a share, compared to $981 million, or...
Posted on 06/06/11 at 9:21am by Benzinga Staff . Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA ) announced today that lipegfilgrastim achieved...
Pentoxifylline is the International Nonproprietary Name (INN) of a drug sold by Aventis under the brand name Trental . PMID 8864715 Pentoxifylline improves blood flow through blood vessels and therefore helps with blood circulation in the arms and legs (e.g. Pentoxifylline has ...
Teva Pharmaceutical Industries (TEVA) Q3 2010 Earnings Call November 02, 2010 8:30 am ET. Today, we are joined by Shlomo Yanai, President and CEO; Eyal Desheh, Chief Financial Officer; Bill Marth, President and CEO of Teva Americas; and Gerard Van Odijk ...
Teva closes $4.95B deal for German drugmaker Ratiopharm, broadens footprint in EuropeTeva Pharmaceutical has solidified operations further in Europe, announcing Tuesday that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.Teva is the world's largest maker of ...
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has completed the acquisition of ratiopharm, Germany's second largest generics producer. We are thrilled to welcome ratiopharm's outstanding team into the Teva family, and we are confident that the combined ...
Teva Pharmaceutical Industries Limited (TEVA) Q2 2010 Earnings Conference Call July 27, 2010 8:30 am ET. Today, we are joined by Shlomo Yanai, President and CEO; Eyal Desheh, Chief Financial Officer; Bill Marth, President and CEO of Teva North America Pharmaceutical ...
Teva Pharmaceutical Industries Limited (TEVA) Q1 2010 Earnings Call Transcript May 04, 2010 9:00 am ET. Today, we are joined by Shlomo Yanai, President and CEO; Eyal Desheh, Chief Financial Officer; Bill Marth, President and CEO of Teva North America; Moshe ...
The speculation over who would acquire Germany's second largest generics drugmaker has ended. In Germany, the second largest generic market in the world, it will be second to Novartis' (NVS) Sandoz, and it will be able to expand in growing generic ...
Teva Pharmaceutical Industries popped another generic pill maker into its portfolio Thursday, the latest acquisition on the its road to becoming one of the world's largest drugmakers.. "Given Teva's strong integration track record, and the potential for meaningful synergies [and ...